D058891Chemicals & DrugsD27.505.519.389.870.200D27.505.696.399.450.855.200670.9923155-alpha Reductase Inhibitorsprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentvivo:hrJobTitleHR job titleInformation ResourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25444984Pascal LE, Masoodi KZ, O'Malley KJ, Shevrin D, Gingrich JR, Parikh RA, Wang ZThe Journal of urology5a-Reductase inhibition coupled with short off cycles increases survival in the LNCaP xenograft prostate tumor model on intermittent androgen deprivation therapy. J Urol. 2015 Apr; 193(4):1388-93.J Urol2014-10-31T00:00:0020145a-Reductase inhibition coupled with short off cycles increases survival in the LNCaP xenograft prostate tumor model on intermittent androgen deprivation therapy.22818135Kaplan SA, Lee RK, Chung DE, Te AE, Scherr DS, Tewari A, Vaughan EDThe Journal of urologyProstate biopsy in response to a change in nadir prostate specific antigen of 0.4 ng/ml after treatment with 5a-reductase inhibitors markedly enhances the detection rate of prostate cancer. J Urol. 2012 Sep; 188(3):757-61.J Urol2012-07-19T00:00:002012Prostate biopsy in response to a change in nadir prostate specific antigen of 0.4 ng/ml after treatment with 5a-reductase inhibitors markedly enhances the detection rate of prostate cancer.OmerRaheemOmer Raheem41.7886000000000087.598699999999994085Raheem, OmerAssociate Professor0.5751510.1103026research area of0.5796050.041489710subject area forMedicineUniversity of ChicagoScott E.EggenerScott E. Eggener41.78927490000000-87.601250000000001156Eggener, Scott E.ProfessorYanLiYan Li41.78927490000000-87.601250000000002065Li, YanCancer BiologySimonHaywardSimon Hayward41.7886000000000087.598699999999994469Hayward, SimonJean Ruggles Romoser Chair of Cancer Research27197599Austin DC, Strand DW, Love HL, Franco OE, Grabowska MM, Miller NL, Hameed O, Clark PE, Matusik RJ, Jin RJ, Hayward SWThe ProstateNF-?B and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance. Prostate. 2016 08; 76(11):1004-18.Prostate2016-05-16T00:00:002016NF-?B and androgen receptor variant 7 induce expression of SRD5A isoforms and confer 5ARI resistance.DanielShevrinDaniel H. Shevrin41.78927490000000-87.60125000000000445Shevrin, DanielCLINICAL ASSOCIATE PROFESSORtrue1true1Jean Ruggles Romoser Chair of Cancer ResearchJean Ruggles Romoser Chair of Cancer Researchtrue1CLINICAL ASSOCIATE PROFESSORCLINICAL ASSOCIATE PROFESSORtrue1ProfessorProfessortrue1Associate ProfessorAssociate ProfessorSurgery-Urology23671262Masoodi KZ, Ramos Garcia R, Pascal LE, Wang Y, Ma HM, O'Malley K, Eisermann K, Shevrin DH, Nguyen HM, Vessella RL, Nelson JB, Parikh RA, Wang ZEndocrinology5a-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models. Endocrinology. 2013 Jul; 154(7):2296-307.Endocrinology2013-05-13T00:00:0020135a-reductase inhibition suppresses testosterone-induced initial regrowth of regressed xenograft prostate tumors in animal models.26990224Chen L, Wang J, Mouser G, Li YC, Marcovici GPhytotherapy research : PTRBlockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays. Phytother Res. 2016 Jun; 30(6):1016-20.Phytother Res2016-03-17T00:00:002016Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine-containing Compound in Prostate and Hair Follicle Cell-based Assays.